Twist Bioscience

About:

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Website: http://www.twistbioscience.com

Twitter/X: TwistBioscience

Top Investors: ARCH Venture Partners, Cormorant Asset Management, Paladin Capital Group, Fidelity, Illumina

Description:

Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development. At Twist Bioscience Corporation, they work in the service of customers who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals, and data storage, by using our synthetic DNA tools, their customers are developing ways to better lives and improve the sustainability of the planet. They believe that the faster their customers succeed, the better for all of them, and Twist Bioscience is uniquely positioned to help accelerate their efforts. Their innovative silicon-based DNA Synthesis Platform provides precision at a scale that we believe is otherwise unavailable to their customers. their platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead. Twist Bioscience was founded in 2013 and is headquartered in San Francisco, California.

Total Funding Amount:

$553M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2013-01-01

Contact Email:

customersupport(AT)twistbioscience.com

Founders:

Bill Banyai, Bill Peck

Number of Employees:

501-1000

Last Funding Date:

2022-02-10

IPO Status:

Public

© 2025 bioDAO.ai